Medicine and Dentistry
Histone Deacetylase Inhibitor
100%
Glioma Cell
85%
Programmed Cell Death
71%
Primary Culture
42%
Combination Therapy
42%
Glioblastoma
28%
G2 Phase Cell Cycle Checkpoint
28%
Therapeutic Procedure
28%
Mitosis Spindle
28%
Clinical Trial
28%
Protein
14%
In Vitro
14%
Cell Growth
14%
DNA Repair
14%
DNA Damage
14%
Cancer Cell
14%
Exercise
14%
Phosphotransferase
14%
Cell Viability
14%
Mitosis
14%
Chromosome Segregation
14%
Cell Cycle Progression
14%
Sodium Valproate
14%
Caspase Inhibitor
14%
Acid
14%
Inpatient
14%
Relapse
14%
Wee1
14%
Survivin
14%
Neuroscience
Histone Deacetylase Inhibitor
100%
Glioma
85%
Glioblastoma Multiforme
28%
Mitosis Spindle
28%
G2 Phase Cell Cycle Checkpoint
28%
Mitotic Catastrophe
28%
In Vitro
14%
Mitosis
14%
Apoptosis
14%
Cell Growth
14%
Reactive Oxygen Species
14%
Kinase
14%
DNA Repair
14%
DNA Damage
14%
Chromosome Segregation
14%
Cell Cycle Progression
14%
Cell Viability
14%
Valproic Acid
14%
Caspase
14%
Survivin
14%
Protein
14%
Checkpoint Kinase 1
14%
Pharmacology, Toxicology and Pharmaceutical Science
Histone Deacetylase Inhibitor
100%
Glioblastoma
28%
Protein
14%
Phosphotransferase
14%
Reactive Oxygen Metabolite
14%
Sodium Valproate
14%
Molecular Target
14%
Acid
14%
Relapse
14%
Survivin
14%
Caspase Inhibitor
14%
Checkpoint Kinase 1
14%